Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

PaperCitations, authors & open-access status

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 540 citations, 2019 year and closed oa status.

540
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Paul DiSilvestro
Author
Yong Li
Author
Amit M. Oza
Author
Bradley J. Monk
Author
The Lancet Oncology
Journal
PARP inhibition in cancer therapy
Topic
470M+ articles · free account